Auditory Research in Children Living With HIV Exposure-uninfected (ARCHIVE)
NCT ID: NCT06635642
Last Updated: 2025-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
35 participants
INTERVENTIONAL
2026-01-01
2030-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining Factors That May Influence Resistance to HIV-1 Infection
NCT00351442
Analysis of HIV-1 Replication During Antiretroviral Therapy
NCT00767312
Clinical Outcomes of People Who Acquired HIV in Early Life
NCT01656564
Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials
NCT00000759
Vitamin D Supplementation in HIV Youth
NCT01523496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Audiological Evaluation: The hearing examination consists of questionnaire, otoscopy, tympanometry, pure-tone air-conduction and bone-conduction audiometry, speech recognition thresholds (SRTs), speech recognition in noise, DDT, and DPOAEs. Questionnaires, otoscopy, and tympanometry can be completed in clinic rooms but pure-tone audiometry, SRTs, DDT, speech recognition in noise, and DPOAEs will be completed in sound treated rooms. The hearing examination portion will take 60 minutes and children will be given breaks when needed. A detailed explanation of the procedures is outlined below.
Questionnaire: The detailed hearing-related health questionnaire will be administered to all participants. Questions will include: whether the child had a newborn hearing screening test, and if so, these data will be extracted from medical records to determine if they passed or failed; history of middle ear involvement; trauma to the ear(s) or head; family history of hearing loss and any other medical-related hearing history, mother/caregiver-perception of any hearing problems, noise exposure, and any previous hearing aid use. The demographic questions will include date of birth, sex, race, primary language spoken, educational level of the child, child's performance at school, caregiver's education level, occupational status, annual income, and family history of hearing loss.
Otoscopy and Tympanometry: In a designated clinic room within the Speech Therapy \& Audiology Clinic at Tygerberg Hospital, an audiologist will perform an otoscopic evaluation on each ear of the child. Information about the presence of debris (e.g., cerumen) in the external ear canal, color and position of the eardrum, and presence/absence of a perforation will be noted. Tympanometry will then be performed by the audiologists. This provides information regarding the functioning of the tympanic membrane. The tympanogram will be a critical component to this proposal, because these measures will most likely identify otitis media in children and poor middle ear function will have a negative, but temporary effect on DPOAEs. If there is an active middle ear involvement based on otoscopy and tympanometry measures, testing will be discontinued, the child will be referred to the Ear, Nose and Throat (ENT) clinic within Tygerberg Hospital, and the child will be rescheduled for testing once the fluid/infection has been resolved and tympanometry is within normal limits.
Pure-tone Hearing Testing: An audiologist will perform all pure-tone audiometric testing using traditional assessment protocols. Pure-tone audiometry using supra-aural earphones will be completed. Testing will be conducted in a sound-treated booth on calibrated equipment. Air conduction (AC) thresholds will be obtained at octave frequencies from 0.25-8 kHz bilaterally. Masking will be used when appropriate. If AC thresholds are \>15 decibels of hearing level (dB HL), a bone conduction (BC) transducer will be placed on the mastoid of the poorer ear, as determined by the air-conduction thresholds. BC thresholds will be determined at 0.5-4 kHz. If air bone gaps are noted, masking to obtain BC thresholds will be used at all frequencies with an air-bone gap ≥15 dB HL.
Distortion Product Otoacoustic Emissions: DPOAEs will be used to assess integrity of cochlear outer hair cell function. DPOAEs will be measured using two primary frequencies (f1 and f2, where f2 \> f1) at f2/f1 = 1.22, f2 swept from 1 through 8 kHz, and a f1 level (L1) of 65 dB of sound pressure level (SPL) and a f2 level (L2) of 55 dB SPL. The child will be instructed to remain as quiet as possible and that they do not need to respond.
Speech Recognition Thresholds: SRT data will be obtained under earphones once pure-tone testing has been completed. The South African Spondaic wordlist will be presented in English and the lowest dB HL level that the child can repeat words 50% correctly will establish the SRT for each ear. Speech recognition in noise testing will then be completed. Presentation level of words will be determined as 50 dB above the SRT for each ear. For example, if the SRT for the right ear was 15 dB HL, then the fixed presentation level for that ear during speech recognition in noise would be 65 dB HL. This ensures a comfortable listening level well above the child's hearing thresholds. The background noise will be set 8 dB HL below the presentation level of the words. And in the example above, the background noise would be set to 57 dB HL. This is a more complex listening setting, but not too difficult for the children to be able to repeat the words that they hear.
Dichotic Digits Testing: DDT will be completed in order to evaluate binaural integration. Testing will be completed under earphones once the SRT has been established. The test will be presented at 50 dB above the SRT, consistent with speech recognition in noise, to ensure a comfortable listening level. The child will be instructed that they will hear two numbers in each ear simultaneously and to listen carefully in both ears and repeat all of the numbers they hear. The repeated order will not matter and guessing the numbers is acceptable. The child will be given practice items before scoring begins. The test will consist of 20 stimulus presentations, or 80 total digits (40 per ear). Numbers between 1-10 (with the exception of 7 due to not being monosyllabic) will be presented in a random order. Scoring for each ear will be calculated as percent correct for each ear.
Intervention: Children who meet the criterion for DDT deficit (\>15% difference between the ears) will be scheduled for 12 Dichotic Interaural Intensity Difference (DIID) training sessions, 20-30 minutes each over a 4-6 week period. Training will take place in the afternoon at the FAMCRU satellite research unit in Khayelitsha, Michael Mapongwana Hospital, which is close to participants homes. Training will be administered using a custom iPad application routed through earphones within a quiet room at FAMCRU satellite research unit. Training will focus on the poorer ear as reflected on DDT scores. The training stimuli are a combination of English digits or consonant-vowel-consonant (CVC) words recorded by a male talker. The dichotic listening tasks focused on binaural integration only. Prior to starting the DIID training, the child's crossover point will be established. The crossover point is the interaural intensity difference (IID) during a dichotic task at which performance in the poorer ear exceeds the better ear. The IID is created when the intensity level of the stimulus in the better ear is decreased while maintaining a constant intensity level in the poorer ear. Training will begin at 50 dB above the SRT in the poorer ear (based on the DDT scores) and at 5 dB above the crossover point for the better ear (based on the DDT scores).
A total of five trials will be presented in a sequence and there will be 10 sequences per training session. Each of the 25 CVC words or digits 1 through 10 (excluding 7) will be presented to each ear during the session. The pairs will be randomized every time, and a word will never be paired with itself. After a sequence is completed, the difficulty of the task will be adjusted, in real time, based on performance on the prior task. If the child scored 4 or 5 of 5 correct in the poorer ear, then the IID will be decreased by 2 dB making the task more difficult. If the child scores 0, 1, or 2 of 5 correct, then the IID will be increased by 2 dB making the task easier. Last, if the child scores 3 of 5 correct, then the IID will remain unchanged for the next sequence.
One month following completion of DIID training, the child will be scheduled for both DDT and speech recognition in noise testing at the Division of Speech-Language and Hearing Therapy at Tygerberg Hospital.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dichotic Interaural Intensity Difference Training
Dichotic Interaural Intensity Difference (DIID) Training
A total of five trials will be presented in a sequence and there will be 10 sequences per training session. Each of the 25 consonant-vowel-consonant words or digits 1 through 10 (excluding 7) will be presented to each ear during the session. The pairs will be randomized every time, and a word will never be paired with itself. After a sequence is completed, the difficulty of the task will be adjusted, in real time, based on performance on the prior task. If the child scored 4 or 5 of 5 correct in the poorer ear, then the IID will be decreased by 2 dB making the task more difficult. If the child scores 0, 1, or 2 of 5 correct, then the IID will be increased by 2 dB making the task easier. Last, if the child scores 3 of 5 correct, then the IID will remain unchanged for the next sequence.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dichotic Interaural Intensity Difference (DIID) Training
A total of five trials will be presented in a sequence and there will be 10 sequences per training session. Each of the 25 consonant-vowel-consonant words or digits 1 through 10 (excluding 7) will be presented to each ear during the session. The pairs will be randomized every time, and a word will never be paired with itself. After a sequence is completed, the difficulty of the task will be adjusted, in real time, based on performance on the prior task. If the child scored 4 or 5 of 5 correct in the poorer ear, then the IID will be decreased by 2 dB making the task more difficult. If the child scores 0, 1, or 2 of 5 correct, then the IID will be increased by 2 dB making the task easier. Last, if the child scores 3 of 5 correct, then the IID will remain unchanged for the next sequence.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Birth weight \>2500g
* No major chromosomal anomalies, neural tube defects, seizures, HIV infection or other medical conditions that influenced neurodevelopmental outcomes and/or confounded the effects of ART and HIV exposure.
Exclusion Criteria
* Caregiver's or the child's refusal to participate
7 Years
9 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Kentucky
OTHER
University of Stellenbosch
OTHER
San Diego State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Torre
Professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1 R01 DC022822-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.